SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-004212
Filing Date
2013-08-06
Accepted
2013-08-06 11:20:23
Documents
14
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 379407
2 CERTIFICATION sbfm_ex311.htm EX-31.1 17218
3 CERTIFICATION sbfm_ex312.htm EX-31.1 17239
4 CERTIFICATION sbfm_ex32.htm EX-32.2 11803
5 img001.jpg GRAPHIC 18668
6 img002.jpg GRAPHIC 20655
7 img003.jpg GRAPHIC 14752
8 img004.jpg GRAPHIC 17382
  Complete submission text file 0001354488-13-004212.txt   1509914

Data Files

Seq Description Document Type Size
9 sbfm-20130630.xml EX-101.INS 35569
10 sbfm-20130630.xsd EX-101.SCH 9618
11 sbfm-20130630_cal.xml EX-101.CAL 22307
12 sbfm-20130630_def.xml EX-101.DEF 9991
13 sbfm-20130630_lab.xml EX-101.LAB 76366
14 sbfm-20130630_pre.xml EX-101.PRE 55020
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 131012341
SIC: 8742 Services-Management Consulting Services